BIONTECH SE revenue for the last year amounted to 59.38 B MXN, the most of which — 62.04 B MXN — came from its highest performing source at the moment, Immunotherapy Technologies, the year earlier bringing 70.13 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought BIONTECH SE 41.67 B MXN, and the year before that — 55.29 B MXN.